MAPT and Alzheimer disease: Our regression models also included cerebrospinal fluid (CSF) markers of amyloid (Aβ42/Aβ40) and phosphorylated tau (p-tau181), along with hippocampal and entorhinal gray matter volumes, which are recognized markers of AD-related pathology.